DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $292,452 | +6.6% | 1,179 | +3.1% | 0.01% | +8.3% |
| Q2 2023 | $274,320 | -4.8% | 1,143 | 0.0% | 0.01% | -20.0% |
| Q1 2023 | $288,081 | -5.0% | 1,143 | 0.0% | 0.02% | -11.8% |
| Q4 2022 | $303,375 | +11.1% | 1,143 | +8.0% | 0.02% | -10.5% |
| Q3 2022 | $273,000 | +32.5% | 1,058 | +30.3% | 0.02% | 0.0% |
| Q2 2022 | $206,000 | -20.2% | 812 | -7.7% | 0.02% | -13.6% |
| Q1 2022 | $258,000 | +7.5% | 880 | 0.0% | 0.02% | +4.8% |
| Q4 2021 | $240,000 | -36.5% | 880 | -29.1% | 0.02% | -34.4% |
| Q3 2021 | $378,000 | +9.9% | 1,242 | +13.8% | 0.03% | 0.0% |
| Q2 2021 | $344,000 | +11.0% | 1,091 | -61.8% | 0.03% | -30.4% |
| Q3 2018 | $310,000 | -13.9% | 2,856 | -32.1% | 0.05% | -51.6% |
| Q1 2017 | $360,000 | +34.8% | 4,206 | +22.7% | 0.10% | -4.0% |
| Q4 2016 | $267,000 | +12.2% | 3,427 | +12.8% | 0.10% | 0.0% |
| Q3 2016 | $238,000 | +14.4% | 3,037 | +38.7% | 0.10% | -22.0% |
| Q1 2016 | $208,000 | -68.0% | 2,190 | -68.7% | 0.13% | -55.1% |
| Q4 2015 | $649,000 | +5800.0% | 6,990 | +4720.7% | 0.28% | +4616.7% |
| Q3 2014 | $11,000 | 0.0% | 145 | 0.0% | 0.01% | +20.0% |
| Q2 2014 | $11,000 | 0.0% | 145 | 0.0% | 0.01% | 0.0% |
| Q1 2014 | $11,000 | -97.4% | 145 | -97.4% | 0.01% | -96.6% |
| Q4 2013 | $424,000 | +15.8% | 5,495 | +4.2% | 0.15% | -20.3% |
| Q3 2013 | $366,000 | +11.2% | 5,275 | +1.4% | 0.19% | -1.6% |
| Q2 2013 | $329,000 | – | 5,200 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |